Syntax Advisors’s Universal Health Services UHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$314K Buy
2,498
+108
+5% +$14.7K 0.28% 75
2023
Q2
$377K Sell
2,390
-496
-17% -$69.2K 0.3% 50
2023
Q1
$367K Buy
2,886
+209
+8% +$28.8K 0.28% 67
2022
Q4
$377K Sell
2,677
-857
-24% -$101K 0.31% 51
2022
Q3
$312K Buy
3,534
+566
+19% +$58.5K 0.27% 69
2022
Q2
$299K Buy
2,968
+810
+38% +$101K 0.25% 80
2022
Q1
$313K Sell
2,158
-712
-25% -$98.5K 0.26% 89
2021
Q4
$372K Buy
+2,870
New +$369K 0.27% 75

Other funds holding UHS

Syntax Advisors's UHS Position: Q3 2023 in Review

Syntax Advisors increased its Universal Health Services (UHS) stake by 4.5% in Q3 2023, buying an estimated $14.7K and bringing the position to 2,498 shares worth $314K. The position accounts for 0.28% of the portfolio, ranked #75.

Syntax Advisors first reported a position in UHS in Q4 2021 and has held it in 8 quarters since. The position peaked at $377K in Q4 2022. 439 funds tracked by Wall St. Rank hold UHS as of Q3 2023.

  • Syntax Advisors held 2,498 shares of Universal Health Services worth $314K as of Q3 2023.
  • Syntax Advisors bought 108 Universal Health Services shares in Q3 2023, an estimated $14.7K.
  • Universal Health Services made up 0.28% of Syntax Advisors's portfolio in Q3 2023, its #75 holding.
  • Syntax Advisors first reported a position in Universal Health Services in Q4 2021 and has held it in 8 quarters since.
  • Syntax Advisors's Universal Health Services position peaked at $377K in Q4 2022.
  • 439 funds tracked by Wall St. Rank held Universal Health Services as of Q3 2023.

Based on Syntax Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.